784 related articles for article (PubMed ID: 24857605)
1. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology-applied curcumin for different diseases therapy.
Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
5. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
Liu J; Chen S; Lv L; Song L; Guo S; Huang S
Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
[TBL] [Abstract][Full Text] [Related]
7. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
8. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review.
Hani U; Shivakumar HG
Curr Drug Deliv; 2014; 11(6):792-804. PubMed ID: 25176028
[TBL] [Abstract][Full Text] [Related]
9. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
10. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
[TBL] [Abstract][Full Text] [Related]
11. Advances in nanotechnology-based delivery systems for curcumin.
Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
[TBL] [Abstract][Full Text] [Related]
12. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
Mohanty C; Sahoo SK
Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
[TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS®.
Kim YH; Lee SJ; Lee SH; Hahn M
Pharm Dev Technol; 2012; 17(6):677-86. PubMed ID: 23216046
[TBL] [Abstract][Full Text] [Related]
14. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
15. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
16. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
[TBL] [Abstract][Full Text] [Related]
18. Curcumin: the story so far.
Sharma RA; Gescher AJ; Steward WP
Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
Zhang Y; Li Z; Huang Y; Xu Y; Zou B
Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
[TBL] [Abstract][Full Text] [Related]
20. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.
Basnet P; Skalko-Basnet N
Molecules; 2011 Jun; 16(6):4567-98. PubMed ID: 21642934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
